A new editorial in JAMA Cardiology has rekindled discussions about the role of aspirin for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and whether there’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results